97精品一区二区视频在线观看,99国产精品久久久久久久成人热,全免费A级毛片免费看

<ul id="saiga"></ul>

<strike id="saiga"></strike>

<ul id="saiga"></ul>

Recombinant Mouse GM-CSF（5ug）

參考價	￥ 720
訂貨量	≥1

具體成交價以合同協議為準

￥720

≥1

具體成交價以合同協議為準

屬性

$NV_PropertyInfoName.SubString(0,25)

在線詢價收藏產品加入對比查看聯系電話

更新時間：2024-07-08 09:10:42瀏覽次數：1157評價

聯系我們時請說明是化工儀器網上看到的信息，謝謝!

全部產品列表

供貨周期	一周	規格	5ug
貨號	abs00994

愛必信特色產品線（全部現貨）：
二抗、標簽抗體、對照抗體；WB相關：ECL發光液、預染marker、預制膠；IHC相關：二抗試劑盒、組化筆；IP/CoIP試劑盒；細胞因子、信號通路調節劑；血清、BSA、蛋白酶K、CTB、TTX、CEE；凋亡試劑盒、呼吸爆發試劑盒；動植物提取物...

概述
種屬	Murine
形態	Lyophilized from a 0.2 μm filtered solution in PBS, pH 7.4.
來源	Escherichia coli.
氨基酸序列	APTRSPITVT RPWKHVEAIK EALNLLDDMP VTLNEEVEVV SNEFSFKKLT CVQTRLKIFE QGLRGNFTKL KGALNMTASY YQTYCPPTPE TDCETQVTTY ADFIDSLKTF LTDIPFECKK PGQK
內毒素水平	Less than 1 EU/μg of rMuGM-CSF as determined by LAL method.
活性	Fully biologically active when compared to standard. The ED₅₀ as determined by a cell proliferation assay using murine FDC-P1 cells is less than 0.05 ng/ml, corresponding to a specific activity of > 2.0 × 10⁷ IU/mg.
Accession #	P01587
預期分子量	Recombinant murine GM-CSF is a 14.1 kDa globular protein consisting of 124 amino acids residues.

性能
溶解方法	We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions.
保存方法	This lyophilized preparation is stable at 2-8 °C, but should be kept at -20 °C for long term storage, preferably desiccated. Upon reconstitution, the preparation is stable for up to one week at 2-8 °C. For maximal stability, apportion the reconstituted preparation into working aliquots and store at -20 °C to -70 °C. Avoid repeated freeze/thaw cycles.
純度	> 98 % by SDS-PAGE and HPLC analyses.
Gene IDs	12981

參考文獻
1. Wang JM, Chen ZG, Colotta F, et al. 1988. Behring Inst Mitt: 270-3.<br/>2. 1989. N Engl J Med, 320: 253-4.<br/>3. Nissen-Druey C. 1989. Nouv Rev Fr Hematol, 31: 99-101.<br/>4. Eager RandNemunaitis J. 2005. Mol Ther, 12: 18-27.<br/>5. Tran T, Fernandes DJ, Schuliga M, et al. 2005. Br J Pharmacol, 145: 123-31.